BRPI0607142A2 - combinações terapêuticas de manidipina e uma estatina, seu uso e um kit - Google Patents

combinações terapêuticas de manidipina e uma estatina, seu uso e um kit

Info

Publication number
BRPI0607142A2
BRPI0607142A2 BRPI0607142-2A BRPI0607142A BRPI0607142A2 BR PI0607142 A2 BRPI0607142 A2 BR PI0607142A2 BR PI0607142 A BRPI0607142 A BR PI0607142A BR PI0607142 A2 BRPI0607142 A2 BR PI0607142A2
Authority
BR
Brazil
Prior art keywords
manidipine
statin
kit
therapeutic combinations
acceptable salt
Prior art date
Application number
BRPI0607142-2A
Other languages
English (en)
Inventor
Roberto Fogari
Carmen Dell Anna
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BRPI0607142A2 publication Critical patent/BRPI0607142A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

COMBINAçõES TERAPêUTICAS DE MANIDIPINA E UMA ESTATINA, SEU USO E UM KIT. Um medicamento consistindo de ( )- 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-3,5-ácido piridino dicarboxílico 2-[4-(difenilmetil) - 1- piperazinil] etil metil éster (manidipina) ou um sal fisiologicamente aceitável e uma estatina ou um sal fisiologicamente aceitável.
BRPI0607142-2A 2005-02-17 2006-02-06 combinações terapêuticas de manidipina e uma estatina, seu uso e um kit BRPI0607142A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05003382 2005-02-17
PCT/EP2006/001024 WO2006087117A1 (en) 2005-02-17 2006-02-06 Therapeutic combinations of manidi pine and a statin

Publications (1)

Publication Number Publication Date
BRPI0607142A2 true BRPI0607142A2 (pt) 2009-08-11

Family

ID=36118210

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607142-2A BRPI0607142A2 (pt) 2005-02-17 2006-02-06 combinações terapêuticas de manidipina e uma estatina, seu uso e um kit

Country Status (16)

Country Link
US (2) US20080070926A1 (pt)
EP (1) EP1848425B1 (pt)
JP (1) JP2008530153A (pt)
KR (1) KR20070111468A (pt)
CN (1) CN101115480A (pt)
AR (1) AR052914A1 (pt)
AT (1) ATE520397T1 (pt)
AU (1) AU2006215855A1 (pt)
BR (1) BRPI0607142A2 (pt)
CA (1) CA2597498A1 (pt)
EA (1) EA200701460A1 (pt)
ES (1) ES2369787T3 (pt)
MX (1) MX2007009779A (pt)
PE (1) PE20061242A1 (pt)
WO (1) WO2006087117A1 (pt)
ZA (1) ZA200706702B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030025A2 (en) * 2006-06-07 2009-03-04 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2010102158A1 (en) * 2009-03-04 2010-09-10 Walter Howard Peschel Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
JP6421535B2 (ja) * 2014-10-14 2018-11-14 日亜化学工業株式会社 発光装置及び表示部並びに制御回路

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
US20050267197A1 (en) * 2004-05-25 2005-12-01 Roger Berlin Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses

Also Published As

Publication number Publication date
WO2006087117A1 (en) 2006-08-24
EP1848425B1 (en) 2011-08-17
KR20070111468A (ko) 2007-11-21
US20100022556A1 (en) 2010-01-28
ZA200706702B (en) 2008-11-26
ES2369787T3 (es) 2011-12-07
AR052914A1 (es) 2007-04-11
JP2008530153A (ja) 2008-08-07
CA2597498A1 (en) 2006-08-24
EA200701460A1 (ru) 2008-02-28
PE20061242A1 (es) 2006-12-21
CN101115480A (zh) 2008-01-30
MX2007009779A (es) 2007-09-26
US20080070926A1 (en) 2008-03-20
EP1848425A1 (en) 2007-10-31
AU2006215855A1 (en) 2006-08-24
ATE520397T1 (de) 2011-09-15

Similar Documents

Publication Publication Date Title
DK2311818T3 (da) Kombination af en 5-phenylthiazolforbindelse som PI3-kinasehæmmer med et antiinflammatorisk, bronchodilatorisk eller antihistaminisk medikament
DK1562946T3 (da) Nye xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
NO20060110L (no) Spesifik glukokortikosteroid forbindelse med anti-inflammatorisk aktivitet
NO20041266L (no) Piperidinderivater som kan anvendes som CCR5-antagonister
IS2980B (is) Aðferðir við að framleiða 4-[[4-[[4-(2-sýanóetenýl)-2,6-dímetýlfenýl]amínó]-2-pýrmídínýl]amínó]bensónítríl
NO20070458L (no) Aryl-pyridinderivater som 11-Beta-HSD1 inhibitorer
DE60201859D1 (de) Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
CY1109240T1 (el) Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο
AR069417A1 (es) Piperidinas heteroaril - sustituidas
CL2008002142A1 (es) Compuestos derivados de 2-amino-6-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}tio)-4-[4-(2-hidroxietoxi) fenil] piridin-3,5-dicarbonitrilo; procedimiento de preparacion; composicion farmaceutica y uso en enfermedades cardiovasculares.
ATE362771T1 (de) Pharmazeutische iressa zusammensetzung enthaltend ein wasserlösliches cellulosederivat
AR074204A1 (es) Arilpiperazinas y su uso como antagonistas alfa -2c
BRPI0616077B8 (pt) composição farmacêutica formulada em uma dose única, kit, artigo de manufatura, uso da composição farmacêutica e uso de um ou mais compostos antidiabéticos
AR031766A1 (es) Terapia
NO20071745L (no) Hydroklorid av 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
NO20053569L (no) Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister
EA200400311A1 (ru) Кристаллы производных гидроксинорэфедрина
AR029758A1 (es) Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen
BRPI0607142A2 (pt) combinações terapêuticas de manidipina e uma estatina, seu uso e um kit
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
DE602006019953D1 (de) Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
ATE538125T1 (de) Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren
BRPI0516200A (pt) forma cristalina do cloridrato de (3-ciano-1h-indol-7-il)-[4-(4-fluorfenetril)piperazin-1-i l]metanona
NO20076396L (no) Substituert akrylamidderivat og farmasoytisk preparat som omfatter dette

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.